[go: up one dir, main page]

US3660464A - Tri-iodinated diaminobenzoic acid derivatives - Google Patents

Tri-iodinated diaminobenzoic acid derivatives Download PDF

Info

Publication number
US3660464A
US3660464A US47908A US3660464DA US3660464A US 3660464 A US3660464 A US 3660464A US 47908 A US47908 A US 47908A US 3660464D A US3660464D A US 3660464DA US 3660464 A US3660464 A US 3660464A
Authority
US
United States
Prior art keywords
bis
tri
carboxy
adipamide
iodophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US47908A
Inventor
Jack Bernstein
Kathryn Alice Losee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of US3660464A publication Critical patent/US3660464A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups

Definitions

  • This invention relates to new radiopaque compounds of the formula COOK COOI-I a a a R 1 3 wherein R, R and R are hydrogen or lower alkyl, R is lower alkyl, X is an alkylene chain containing up to 10 carbon atoms, which may be interrupted by heterocyclic atoms such as oxygen, sulfur or and to the basic salts of these compounds, e.g., alkali metal salts such as sodium and potassium, alkaline earth salts such as calcium, ammonium salts and amine salts, such as N-methylglucamine, as well as lower aliphatic esters such as the methyl, ethyl and butyl esters.
  • the new compounds of the present invention include the following types of compounds as well as the abovementioned basic salts and aliphatic esters thereof: N,N- bis[5 (alkylureido) 3 carboxy 2,4,6-tri-iodophenyl] adipamides, such as N,N-bis [5- B-methylureido) -3 -carb oxy-2,4,6-tri-iodophenyl] adipamide,
  • N,N-bis[5- (dialkylureido -3-carboxy-2,4,6-tri-iodophenyl] adipamides such as N,N'-bis [5- (3,3-dimethylureido) -3-carboXy-2,4,6-triiodophenyl] adipamide
  • N,N-bis [5- (trialkylureido -3-carboxy-2,4,6-tri-iodophenyl] adipamides such as N ,N-bis 5 l,3,3-trimethylureido -3-carboXy-2,4,6-triiodophenyl] adipamide;
  • tri-iodophenyl] adipamides such as N,N'-diethyl-N,N'-bis [5- 3-methylureido -3-carb0xy- 2,4,6-tri-iodophenyl] adipamide;
  • N,N'-dialkyl-N,N-bis [5- (dialkylureido) -3-carboxy- 2,4,6-tri-iodophenyl] adipamides such as N,N'-diethyl-N,N'-bis 5-'( 3,3-dimethylureido -3-carboxy-2,4,fi-tri-iodophenyl]adipamide and N ,N'-diethyl-N,N'-bis [5 1,3-dimethylureid0 -3-carboxy-2,4,fi-tri-iodophenyl] adipamide; and
  • N,N-dialkyl-N,N-bis [5- (trialkylureido) -3-carboxy- 2,4,6-tri-iodophenyl] adipamides such as N,N'-diethyl-N,N'-bis [5-( 1,3,3-trimethylu1'eido) -3-carboxy-Z,4,6-tri-iodophenyl] adipamide
  • the compounds of this invention may be prepared by the reaction of a compound of formula coon coon I I I I mix rlr-co-x-co-rii rim R1 I R R R1 with an alkyl isocyanate of the formula III R NCO or a dialkylcarbamoyl halide of the formula N-CO-Y R wherein Y is halogen, preferably chlorine and R, R R R and X are as previously defined.
  • the reaction is carried out in an inert solvent such as ethylene glycol dimethyl ether, diethylene glycol dimethyl ether or dimethyl formamide.
  • the reaction is preferably carried out in the presence of a hydrogen halide acceptor such as pyridine, N-methylmorpholine, triethylamine and the like.
  • a hydrogen halide acceptor such as pyridine, N-methylmorpholine, triethylamine and the like.
  • the hydrogen halide acceptor may also be used as a solvent for the reaction.
  • the compounds of the Formula II may be prepared by the iodination of a compound of the formula OOl-I coon l p-co-x co-u rim R R R with iodine chloride in aqueous medium or with sodium or potassium iododichloride in aqueous medium.
  • the compounds of Formula V in which R is hydrogen may be prepared by the reduction of a nitro compound of the formula COOH COOl-I
  • the compounds of Formula V in which R is lower alkyl may be prepared by the reduction of the Scange base of a compound of Formula V in which R is hydrogen.
  • the lower alkyl groups R, R and R include straight or branched alkyl chains of up to 6 carbon atoms such as methyl, ethyl, propyl, i-propyl, n-butyl, i-butyl, n-pentyl, Z-methylbutyl, neopentyl, n-hexyl, 2-methylpentyl, 3- methylpentyl, 2,2-dimethylbutyl, and 2,3-dimethylbutyl.
  • the new products of Formula I are useful as radiopaque agents for visualization of animal systems or organs, preferably in the form of physiologically acceptable salts such as sodium or methylglucamine salts for the preparation of solutions for intravascular injection for urography and for vasographic techniques such as angiocardiography, arteriography, nephrography and venography.
  • the water-insoluble esters are useful in visualizing hollow organs and cavities having external orifices through which the contrast preparation can be introduced in preparation for the examination and removal after the examination is completed. Solutions having about to bound iodine, preferably about 37%, may be used, or on a weight basis from about 20 g. to about g. of a compound of Formula I per ml. of water.
  • the product is then suspended in dilute hydrochloric acid, filtered and washed with water to yield the desired N,N'-bis[5- nitro-3-carboxyphenyl]adipamide.
  • the product may be purified by crystallization of the ammonium salt and conversion to the free acid, which melts at about 300.
  • the solid is washed with water and dried at 50 under reduced pressure to yield the desired N,N'-bis[5-amino 3 carboxy-2,4,6-tri-iodophenyl]adipamide.
  • the product which does not melt below 300, may be purified by crystallization of its ammonium salt.
  • the precipitated solid is filtered, washed with water and dried under reduced pressure at 100 to yield the desired N,N'-bis[5-(3-methylureido) 3 carboxy-2,4,6-tri-iodophenyl] adipamide.
  • the precipitated solid is filtered, dissolved in dilute aqueous sodium hydroxide and treated with decolorizing carbon.
  • the solution is filtered and made strongly acid with hydrochloric acid.
  • the solid is filtered, Washed with water and dried at 60 under reduced pressure to yield the desired N,N-bis[5-(3,3-dimethylureido)-3-carboxy-2,4,6-tri iodophenyl1adipamide.
  • EXAMPLE 6' N,N'-bis [5-( l-ethyl-3-methylureido) -3-carboxy- 2,4,6-tri-iodophenyl] adipamide (a) N,N' bis[5 ethylamino 3 carboxyphenyl] adipamide.A mixture of 10 grams of N,N-bis[5-amino- 3-carboxyphenyl1adipamide and 5 ml. of acetaldehyde in 200 ml. of absolute ethanol is allowed to stand for 12 hours and is then hydrogenated at room temperature and pressure using 5 grams of Raney niekel'as the catalyst. The catalyst is filtered and the filtrate concentrated under reduced pressure to yield the desired N,N'-bis[5-ethylamino-3-carboxyphenyl]adipamide. The product may be purified by crystallization from aqueous alcohol.
  • R, R and R are hydrogen or lower alkyl of up to 6 carbon atoms, R is lower alkyl of up to 6 carbon atoms, X is an alkylene chain of up to 10 carbon atoms which may be interrupted by heterocyclic atoms selected from the group consisting of oxygen, sulfur or as well as lower alkyl esters and physiologically acceptable salts thereof wherein the alkyl ester has up to 6 carbon atoms.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

THIS INVENTION RELATES TO NEW IODINATED DIAMINOBENZOIC ACID DERIVATIVES OF THE GENERAL FORMULA

1-(HOOC-),2,4,6-TRI(I-),3-(R2-N(-R3)-CO-N(-R1)-),5-

((2,4,6-TRI(I-),3-(R2-N(-R3)-CO-N(-R1)-),5-(HOOC-)-

PHENYL)-N(-R)-CO-ALKYLENE-CO-N(-R)-)BENZENE

AND TO SALTS AND LOWER ALKYL ESTERS OF THESE COMPOUNDS,

Description

United States Patent Office 3,660,464 TRI-IODINATED DIAMINOBENZOIC ACID DERIVATIVES Jack Bernstein and Kathryn Alice Losee, New Brunswick, N.J., assiguors to E. R. Squibb & Sons, Inc., New York, N.Y. N Drawing. Filed June 19, 1970, Ser. N0. 47,908 Int. Cl. C07c 127/16 US. Cl. 260-470 6 Claims ABSTRACT OF THE DISCLOSURE This invention relates to new iodinated diaminobenzoic acid derivatives of the general formula and to salts and lower alkyl esters of these compounds, which are useful as radiopaque agents.
It is an obect of the present invention to provide new compounds which are useful radiopaque agents. Another object is to provide methods for the preparation of these compounds. These and other objects of the present invention will be apparent from the following description.
SUMMARY OF THE INVENTION This invention relates to new radiopaque compounds of the formula COOK COOI-I a a a R 1 3 wherein R, R and R are hydrogen or lower alkyl, R is lower alkyl, X is an alkylene chain containing up to 10 carbon atoms, which may be interrupted by heterocyclic atoms such as oxygen, sulfur or and to the basic salts of these compounds, e.g., alkali metal salts such as sodium and potassium, alkaline earth salts such as calcium, ammonium salts and amine salts, such as N-methylglucamine, as well as lower aliphatic esters such as the methyl, ethyl and butyl esters.
The new compounds of the present invention include the following types of compounds as well as the abovementioned basic salts and aliphatic esters thereof: N,N- bis[5 (alkylureido) 3 carboxy 2,4,6-tri-iodophenyl] adipamides, such as N,N-bis [5- B-methylureido) -3 -carb oxy-2,4,6-tri-iodophenyl] adipamide,
N,N'-bis [5- 3-ethylureido -3 -carboxy-2,4,6-tri-iodophenyl] adipamide and N,N'-bis 5- 3-n-butylureido -3-carboxy-2,4,6-tri-iodophenyl] adipamide;
N,N-bis[5- (dialkylureido -3-carboxy-2,4,6-tri-iodophenyl] adipamides, such as N,N'-bis [5- (3,3-dimethylureido) -3-carboXy-2,4,6-triiodophenyl] adipamide,
N,N-bis [5-( 1,3-dimethylureido -3-carb oxy-2,4,6-triiodophenyl] adipamide,
N,N'-bis [5-( 1-methyl-3-ethylureido -3 -carboxy-2,4,6-
tri-iodophenyl] adipamide and N,N'-bis [5-( l-ethyl-3 -methylureido) -3-carb wry-2,4,6-
tri-iodophenyl] adipamide;
Patented May 2, 1972 N,N-bis [5- (trialkylureido -3-carboxy-2,4,6-tri-iodophenyl] adipamides, such as N ,N-bis 5 l,3,3-trimethylureido -3-carboXy-2,4,6-triiodophenyl] adipamide;
N,N-dialkyl-N,N'-bis [5- alkylureido) -3-carboXy-2,4,6-
tri-iodophenyl] adipamides, such as N,N'-diethyl-N,N'-bis [5- 3-methylureido -3-carb0xy- 2,4,6-tri-iodophenyl] adipamide;
N,N'-dialkyl-N,N-bis [5- (dialkylureido) -3-carboxy- 2,4,6-tri-iodophenyl] adipamides, such as N,N'-diethyl-N,N'-bis 5-'( 3,3-dimethylureido -3-carboxy-2,4,fi-tri-iodophenyl]adipamide and N ,N'-diethyl-N,N'-bis [5 1,3-dimethylureid0 -3-carboxy-2,4,fi-tri-iodophenyl] adipamide; and
N,N-dialkyl-N,N-bis [5- (trialkylureido) -3-carboxy- 2,4,6-tri-iodophenyl] adipamides, such as N,N'-diethyl-N,N'-bis [5-( 1,3,3-trimethylu1'eido) -3-carboxy-Z,4,6-tri-iodophenyl] adipamide,
as well as the corresponding derivatives of succinamide, glutararnide, suberamide, pimelamide, sebacamide, 3- oxaglutaramide and 3-methyl-3-azaglutaramide.
The compounds of this invention may be prepared by the reaction of a compound of formula coon coon I I I I mix rlr-co-x-co-rii rim R1 I R R R1 with an alkyl isocyanate of the formula III R NCO or a dialkylcarbamoyl halide of the formula N-CO-Y R wherein Y is halogen, preferably chlorine and R, R R R and X are as previously defined. The reaction is carried out in an inert solvent such as ethylene glycol dimethyl ether, diethylene glycol dimethyl ether or dimethyl formamide. When a compound of Formula IV is one of the reactants, the reaction is preferably carried out in the presence of a hydrogen halide acceptor such as pyridine, N-methylmorpholine, triethylamine and the like. In such cases, the hydrogen halide acceptor may also be used as a solvent for the reaction.
The compounds of the Formula II may be prepared by the iodination of a compound of the formula OOl-I coon l p-co-x co-u rim R R R R with iodine chloride in aqueous medium or with sodium or potassium iododichloride in aqueous medium.
The compounds of Formula V in which R is hydrogen may be prepared by the reduction of a nitro compound of the formula COOH COOl-I The compounds of Formula V in which R is lower alkyl may be prepared by the reduction of the Schilf base of a compound of Formula V in which R is hydrogen.
Compounds of the Formula VI are prepared by treatment of a compound of the Formula VII v II lC OH An alternate synthesis for the compounds of Formula I is the reaction of a compound of the formula with a compound of the Formula VIII. Compounds of the Formula IX are described in our copending application Ser. No. 47,902, filed concurrently herewith.
The lower alkyl groups R, R and R include straight or branched alkyl chains of up to 6 carbon atoms such as methyl, ethyl, propyl, i-propyl, n-butyl, i-butyl, n-pentyl, Z-methylbutyl, neopentyl, n-hexyl, 2-methylpentyl, 3- methylpentyl, 2,2-dimethylbutyl, and 2,3-dimethylbutyl.
The new products of Formula I are useful as radiopaque agents for visualization of animal systems or organs, preferably in the form of physiologically acceptable salts such as sodium or methylglucamine salts for the preparation of solutions for intravascular injection for urography and for vasographic techniques such as angiocardiography, arteriography, nephrography and venography. The water-insoluble esters are useful in visualizing hollow organs and cavities having external orifices through which the contrast preparation can be introduced in preparation for the examination and removal after the examination is completed. Solutions having about to bound iodine, preferably about 37%, may be used, or on a weight basis from about 20 g. to about g. of a compound of Formula I per ml. of water.
The following examples illustrate the present invention without, however, limiting the same thereto. All temperatures are on the centigrade scale.
EXAMPLE 1 N,N'-bis[5-(3-methylureido)-3-carboxy- 2,4,6-tri-iodophenyl] adipamide (a) N,N-bis[5-nitro 3 carboxyphenyl]adipamide. To a solution of 10 grams of 3-amino-5-nitrobenzoic acid in 75 ml. of toluene there is slowly added 4.5 grams of adipoyl chloride and the reaction mixture heated on a steam bath for six hours. The reaction mixture is cooled, and the solid filtered, washed with toluene and air-dried. It is then suspended in dilute hydrochloric acid, filtered and washed with water to yield the desired N,N'-bis[5- nitro-3-carboxyphenyl]adipamide. The product may be purified by crystallization of the ammonium salt and conversion to the free acid, which melts at about 300.
(b) N,N'-bis[5 amino-3-carboxyphenyl]adipamide.- To a solution of 10 grams of N,N-bis[5-nitro-3-carboxyphenyl]adipamide in an equivalent amount of dilute aqueous sodium hydroxide there is added one gram of Raney nickel catalyst and the reaction mixture shaken in a Parr hydrogenation apparatus at 50 p.s.i. of hydrogen until the theoretical amount of hydrogen is absorbed. The mixture is filtered and the filtrate neutralized with acetic acid. The precipitated solid is filtered, washed with water and dried to yield the desired N,N-bis[5-amino-3-carboxyphenyl]adipamide, which melts at about 310 with decomposition.
(c) N,N-bis[5-amino 3 carboxy-2,4,6-tri-iodophenyl]adipamide.To a mixture of 13.3 grams of N,N'-bis [S-amino 3 carboxyphenynadipamide and 400 ml. of water there is added slowly, with vigorous stirring, 100 ml. of 2 N aqueous potassium iodochloride solution. The reaction mixture is stirred for twenty-four hours at room temperature and is then filtered. The solid thus obtained is dissolved in dilute aqueous sodium hydroxide, treated with aqueous sodium bisulfite and filtered. The filtrate is neutralized with dilute hydrochloric acid and the precipitate collected by filtration. The solid is washed with water and dried at 50 under reduced pressure to yield the desired N,N'-bis[5-amino 3 carboxy-2,4,6-tri-iodophenyl]adipamide. The product, which does not melt below 300, may be purified by crystallization of its ammonium salt.
(d) N,N-bis[5 (3-methylureido)-3-carboxy-2,4,6 triiodophenyl]adipamide.A mixture of 2 grams of N,N'- bis[5-amino 3 carboxy-2,4,6-tri-iodophenyl]adipamide, 2 ml. of methyl isocyanate and 100 ml. of ethylene glycol dimethyl ether is heated to reflux for twenty-four hours. The solvent is removed by distillation under reduced pressure and the residue treated with dilute hydrochloric acid. The precipitated solid is filtered, dissolved in dilute alkali and treated with decolorizing carbon. The solution is filtered and made strongly acid with 20% hydrochloric acid. The precipitated solid is filtered, washed with water and dried under reduced pressure at 100 to yield the desired N,N'-bis[5-(3-methylureido) 3 carboxy-2,4,6-tri-iodophenyl] adipamide.
Following this general procedure but substituting in part (a) equivalent amounts of the acyl chlorides derived from succinic acid, glutamic acid, suberic acid, pimelic acid, sebacic acid, 3-oxaglutaric acid and 3-methyl-3-azaglutaric acid, there is obtained N,N'-bis [5- 3-methylureido -3-carboxy-2,4,6-tri-iodophenyl] succinamide,
N,N'-bis [5- 3-methylureido -3-carboxy-2,4,6-tri-iodophenyl] glutaramide,
N,N-bis 5- 3-methylureido -3-carboxy-2,4,6-tri-iodophenylJsuberamide,
N,N-bis [5- 3-methylureido -3-carboxy-2,4,6-tri iodophenyl] pimelamide,
N,N'-bis [5- 3-methylureido -3-carboxy-2,4,6-tri-iodophenyl] sebacamide,
N,N'-bis 5- S-methylureido -3-carboxy-2,4,6-tri-iodophenyl]-3-oxaglutaramide and N,N'-bis [5- 3-methylureido -3-carboxy2,4,6-tri-iodophenyl] -3-methyl-3-azaglutaramide,
respectively.
EXAMPLE 2 N,N-bis [5-( 3-ethylureido)-3-carboxy- 2,4,6-tri-iodophenyl]adipamide Following the procedure of Example 1d, but substituting an equivalent amount of ethyl isocyanate for the methyl isocyanate, there is obtained the desired N,N-bis[5-(3- ethylureido)-3-carboxy-2,4,6-tri-iodophenyl]adipamide.
EXAMPLE 3 N,N-bis[5-(3-n-butylureido)-3-carboxy- 2,4,6-tri-io dophenyl] adipamide Following the procedure of Example 1d but substituting an equivalent amount of n-butyl isocyanate for the methyl isocyanate, there is obtained the desired N,N-bis [5-(3-n-butylureido) 3 carboxy-2,4,6-tri-iodophenyl] adipamide.
EXAMPLE 4 N,N-dimethyl-N,N-bis[5-(S-methylureido)-3-carboxy- 2,4, 6-tri-iodophenyl] adipamide Following the procedure of Example 1, but substituting an equivalent amount of 3-methylamino-S-nitrobenzoic acid for the 3-amino-5-nitrobenzoic acid in part (a), there is obtained the desired N,N'-dimethyl-N,N-bis[5-(3meth ylureido -3 -carboxy-2,4, 6-tri-iodophenyl] adip amide.
Similarly by substituting equivalent amounts of 3-ethylamino-S-nitrobenzoic acid and Z-n-butyl-amino-S-nitrobenzoic acid for the 3-amino-5-nitrobenzoic acid, there is obtained N,N'-diethyl-N,N-bis 5- 3-methylureido)-3-ca-rboxy-2,4,fi-tri-iodophenyl]adipamide and N,N'-di-n-butyl- N,N'-bis[5-(3-rnethylureido) 5 carboxy-2,4,6-tri-iodophenyl1adipamide.
EXAMPLE 5 N,N'-bis[5- (3,3-dimethylureido)-3-carboxy- 2,4,6-tri-iodophenyl] adipamide To a stirred mixture of 2 grams of N,N-bis[5-amino- 3-carboxy-2,4,6-tri-iodophenyl]adipamide in 20 ml. of anhydrous pyridine there is added dropwise with cooling, a solution of 1 gram of dimethylcarbamoyl chloride in ml. of anhydrous benzene. The reaction mixture is stirred for two hours and is then concentrated under reduced pressure to remove the benzene. The residue is mixed with ice and dilute hydrochloric acid. The precipitated solid is filtered, dissolved in dilute aqueous sodium hydroxide and treated with decolorizing carbon. The solution is filtered and made strongly acid with hydrochloric acid. The solid is filtered, Washed with water and dried at 60 under reduced pressure to yield the desired N,N-bis[5-(3,3-dimethylureido)-3-carboxy-2,4,6-tri iodophenyl1adipamide.
Similarly by employing an equivalent amount of diethylcarbamoyl chloride for the dimethylcarbamoyl chloride there is obtained the desired N,N'-bis[5-(3,3-diethylureido) -3-carboxy-2,4,6-tri-iodophenyl] adipamide.
EXAMPLE 6' N,N'-bis [5-( l-ethyl-3-methylureido) -3-carboxy- 2,4,6-tri-iodophenyl] adipamide (a) N,N' bis[5 ethylamino 3 carboxyphenyl] adipamide.A mixture of 10 grams of N,N-bis[5-amino- 3-carboxyphenyl1adipamide and 5 ml. of acetaldehyde in 200 ml. of absolute ethanol is allowed to stand for 12 hours and is then hydrogenated at room temperature and pressure using 5 grams of Raney niekel'as the catalyst. The catalyst is filtered and the filtrate concentrated under reduced pressure to yield the desired N,N'-bis[5-ethylamino-3-carboxyphenyl]adipamide. The product may be purified by crystallization from aqueous alcohol.
(b) N,N' bis[5 ethylamino-3-carboxy-2,4,6-triiodophenyl]adipamide.-Following the procedure of Example 1(c), but substituting an equivalent amount of N,N-bis [5-ethylamino-3-carboxyphenyl]adipamide for the N,N'- bis [5-amino-3-carboxyphenyl]adipamide, there is obtained the desired N,N bis[5 ethylamino-3-carboxy-2,4,6-triiodophenyl1adipamide.
(c) N,N bis[5 (l-ethyl-3-metltylureido)-3-carboxy- 2,4,6-tri-iod0phenyl] adipamide.Following the procedure of Example 1(d), but substituting an equivalent amount of N,N bis[5 ethylamino-3-carboxy 2,4,6-tri-iodophenyl] adipamide for the N,N'-bis[5-amin0-3- carboxy-2,4,6-triiodophenyl1adipamide, there is obtained the desired N,N'- bis[5 (l ethyl 3 -methylureido)-3-carboxy-2,4,6-triiodophenyl] adipamide.
EXAMPLE 7 N,N-bis [5-( 1-ethyl-3 ,3-dimethylure ido) -3-carboxy- 2,4,6-tri-iodophenyl] adipamide Following the procedure of Example 5, but substituting an equivalent amount of N,N-bis[5-ethylamino-3-carboxy-2,4,6-tri-iodophenyl]adipamide for the N,N'-bis[5- amino-3-carboxy-2,4,6-tri-iodophenyl]adipamide, there is (a) N,N'-dimethyl-N,N-bis[5-amino-3-carboxyphenyl] I adipamide. FOIIOwing the procedure of Example 1(a), (b), but substituting an equivalent amount of 3-methylamino-S-nitrobenzoic acid for the 3-amino-5-nitrobenzoic acid in part (a), there is obtained the desired N,N-dimethyl-N,N-bis[5-amino3-carboxyphenyl]adipamide.
(b) N,N dimethyl N,N bis[5-ethylamino-3-carboxy- 2,4,6-tri-iodophenyl] adipamide.-Following the procedure 7 of Example 6(a), (b), but substituting an equivalent amount of N,N' dimethyl N,N'-bis[5-ethylamino-3-carboxyphenyl1adipamide for the N,N'-bis[5-amino-3-carboxyphenyl1adipamide in part -(a), there is obtained the desired N,N'-dimethyl-N,N' bis[5-ethylamino-3-carboxy- 2,4,6-tri-iodophenyl] adipamide.
(c) N,N' dimethyl N,N' bis[5-(l-ethyl-3-methylureido) 3 carboxy-2,4,6-tri-iodophenyl]adipamide.- Following the procedure of Example 1(d), but substituting an equivalent amount of N,N'-dirnethyl-N,N'-bis[5- ethylamino 3 carboxy 2,4,6-tri-iodophenyl] adipamide for the N,N'-bis[5-amin0-3-carboxy-2,4,6-tri-iodophenyl] adipamide, there is obtained the desired N,N'-dimethyl- N,N' bis[5 (1 ethyl 3 methylureido)-3-carboxy- 2,4,6-tri-io dophenyl] adipamide.
Similarly, but substituting an equivalent amount of 5-ethylamino-3-nitrobenzoic acid for the 5-methylamino-3- nitrobenzoic acid in part (a), there is obtained N,N-diethyl N,N' bis[5-('l-ethyl-3-methylureido)3-carboxy- 2,4,6-tri-iodophenyl] adipamide.
EXAMPLE 9 N,N'-dimethyl-N,N'-bis 5-( 1-ethyl-3,3-dimethylureido) 3-carboxy-2,4,6-tri-iodophenyl] adipamide Following the procedure of Example 5, but substituting an equivalent amount of N,N' dimethyl N,N bis[5- ethylamino-3-carboxy-2,4,6-tri-iodophenyl]adipamide for the N,N' bis[5 amino-3-carboxy-2,4,-tzi-iodophenyl] adipamide, there is obtained the desired N,N-dimethyl- N,N' bis[5 (l ethyl-3,3-dimethylureido)-3-carboxy- 2,4,6-tri-iodophenyl] adipamide.
EXAMPLE l0 N,N'-bis[5-(1,3,3-trimethylureido)-3-carboxy-2,4,6- tri-iodophenyl1adipamide Following the procedure of Example 1(a), but substituting 3 grams of 3-amino-5-(l,3,3-trimethylureido)- 2,4,6-tri-iodobenz0ic acid for the 3-amino-5-nitrobenzoic acid, there is obtained the desired N,N' bis[5-(l,3,3-trimethylureido) -3-carboxy-2,4,6-tri-iodophenyl] adipamide.
EXAMPLE 1 l N,N-bis [5- 3-methylureido -3-carbomethoxy-2,4,6- tri-ibdophenyl1adipamide Following the general procedure of Example 1, but substituting an equivalent amount of methyl 3-amino-5- nitrobenzoate for the 3-amino-5-nitrobenzoic acid, there is obtained the desired N,N-bis[5-(3-methylureido)-3- carbomethoxy-2,4,6-tri-iodophenyl] adipamide.
EXAMPLE l2 N,N' dimethyl N,N' bis[5 (3-methylureido)-3- carbethoxy-2,4,6-tri-iodophenyl] adipamide To a mixture of 20 grams of N,N-dimethyl-N,N'-bis [5 (3 methylureido) 3-carboxy-2,4,6-tri-iodophenyl] adipamide and ml. of absolute ethanol there is added a solution of 2 grams of potassium hydroxide in 50 ml. of absolute ethanol. There is then added 4.5 ml. of diethyl sulfate and the reaction mixture is stirred for twenty-four N,N'-bis 5- 3-methylureido) -3-carboxy-2,4,6-triiodophenyl] -3-thiaglutaramide Following the procedure of Example 1, but substituting in part (a) an equivalent amount of the acyl chloride derived from 3-thiaglutaric acid, there is obtained N,N- bis [5- 3-methylureido -3-carboxy-2,4,6-tri-iodophenyl] -3 thiaglutaramide.
What is claimed is:
1. A compound of the formula COOH C0011 3 wherein R, R and R are hydrogen or lower alkyl of up to 6 carbon atoms, R is lower alkyl of up to 6 carbon atoms, X is an alkylene chain of up to 10 carbon atoms which may be interrupted by heterocyclic atoms selected from the group consisting of oxygen, sulfur or as well as lower alkyl esters and physiologically acceptable salts thereof wherein the alkyl ester has up to 6 carbon atoms.
2. A compound of claim 1 wherein R, R and R are hydrogen.
3. A compound of claim 1 wherein R, R and R are lower alkyl.
4. A compound of claim 1 wherein one R is hydrogen and the other R is lower alkyl.
5. A compound of claim 1 wherein one R is hydrogen and the other R is lower alkyl.
6. A compound of claim 1 wherein one R is hydrogen and the other R is lower alkyl.
References Cited Fieser, L. F., et al., Organic Chemistry, 3rd ed. (1956), pub. by Reinhold Pub. Corp., New York, p. 608 cites.
LORRAINE A. WEINBERGER, Primary Examiner L. A. THAXT ON, Assistant Examiner US. Cl. X.R.
260--47*l R, 501.11, 516, 518 A, 519; 4245
US47908A 1970-06-19 1970-06-19 Tri-iodinated diaminobenzoic acid derivatives Expired - Lifetime US3660464A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4790870A 1970-06-19 1970-06-19

Publications (1)

Publication Number Publication Date
US3660464A true US3660464A (en) 1972-05-02

Family

ID=21951690

Family Applications (1)

Application Number Title Priority Date Filing Date
US47908A Expired - Lifetime US3660464A (en) 1970-06-19 1970-06-19 Tri-iodinated diaminobenzoic acid derivatives

Country Status (5)

Country Link
US (1) US3660464A (en)
CH (1) CH542822A (en)
DE (1) DE2130369A1 (en)
FR (1) FR2100793B1 (en)
HU (1) HU163045B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4014986A (en) * 1974-05-31 1977-03-29 Laboratoires Andre Guerbet X-ray contrast media
US4065554A (en) * 1974-05-31 1977-12-27 Laboratoires Andre Guerbet X-ray contrast media
US4132731A (en) * 1976-06-25 1979-01-02 Schering Aktiengesellschaft Novel iodized isophthalamic acid compounds
US4239747A (en) * 1976-06-23 1980-12-16 Schering Aktiengesellschaft Dicarboxylic acid bis(3,5-dicarbamoyl-2,4,6-triiodoanilides) useful as x-ray contrast agents
US4395391A (en) * 1980-11-25 1983-07-26 Schering Aktiengesellschaft Unsymmetrically substituted dicarboxylic-acid-bis-(2,4,6-triiodo-anilides), their preparation, and x-ray contrast media containing same
US5066823A (en) * 1987-05-22 1991-11-19 Bracco Industria Chemica S.P.A. Preparation of 5-acylamino-2,4,6-triiodo- or tribromo-benzoic acid derivatives
WO2019177740A1 (en) * 2018-03-12 2019-09-19 Boston Scientific Scimed, Inc. Scavenging methods, and scavenging system for radiocontrast agents
US11597792B2 (en) * 2017-10-30 2023-03-07 The Texas A&M University System Radiopaque thermoplastic polymer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660469A (en) * 1969-08-04 1972-05-02 Squibb & Sons Inc Bis-triiodoisophthalamic acid compounds

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4014986A (en) * 1974-05-31 1977-03-29 Laboratoires Andre Guerbet X-ray contrast media
US4065554A (en) * 1974-05-31 1977-12-27 Laboratoires Andre Guerbet X-ray contrast media
US4065553A (en) * 1974-05-31 1977-12-27 Laboratoires Andre Guerbet X-Ray contrast media
US4239747A (en) * 1976-06-23 1980-12-16 Schering Aktiengesellschaft Dicarboxylic acid bis(3,5-dicarbamoyl-2,4,6-triiodoanilides) useful as x-ray contrast agents
US4132731A (en) * 1976-06-25 1979-01-02 Schering Aktiengesellschaft Novel iodized isophthalamic acid compounds
US4395391A (en) * 1980-11-25 1983-07-26 Schering Aktiengesellschaft Unsymmetrically substituted dicarboxylic-acid-bis-(2,4,6-triiodo-anilides), their preparation, and x-ray contrast media containing same
US5066823A (en) * 1987-05-22 1991-11-19 Bracco Industria Chemica S.P.A. Preparation of 5-acylamino-2,4,6-triiodo- or tribromo-benzoic acid derivatives
US11597792B2 (en) * 2017-10-30 2023-03-07 The Texas A&M University System Radiopaque thermoplastic polymer
WO2019177740A1 (en) * 2018-03-12 2019-09-19 Boston Scientific Scimed, Inc. Scavenging methods, and scavenging system for radiocontrast agents
US11213596B2 (en) 2018-03-12 2022-01-04 Boston Scientific Scimed, Inc. Radiocontrast agents, scavenging methods, and scavenging system

Also Published As

Publication number Publication date
CH542822A (en) 1973-10-15
DE2130369A1 (en) 1971-12-23
FR2100793A1 (en) 1972-03-24
FR2100793B1 (en) 1974-08-30
HU163045B (en) 1973-05-28

Similar Documents

Publication Publication Date Title
US2776241A (en) Injectable x-ray contrast agents comprising salts of n-acyl derivatives of 2, 4, 6-triiodo-3-aminobenzoic acid
AU616203B2 (en) New dicarboxylic acid-bis(3,5-dicarbamoyl-2,4,6- triiodoanilides), process for their production as well as x- ray contrast media containing them
DK159772B (en) TRIJOD ISOPHTHALIC ACID DIAMIDS AND XENTIC CONTRAST AGENTS CONTAINING THESE COMPOUNDS
CA1086328A (en) X-ray contrast media
US3660464A (en) Tri-iodinated diaminobenzoic acid derivatives
DK159846B (en) NON-IONIC 5-C-SUBSTITUTED 2,4,6-TRIODISOPHTHALIC ACID DERIVATIVES AND ROENTGEN CONTRAST AGENTS CONTAINING THESE
AU654341B2 (en) New polyiodated compounds, method of preparation, contrast product containing them
KR101888392B1 (en) Manufacture of a triiodinated contrast agent
US2676188A (en) Acylated glycinamides
US3409662A (en) 3, 3'-diamino-5, 5'-dicarboxy-hexaiodocarbanilides and derivatives
CA2020489C (en) Carboxamide non-ionic contrast media
US3732293A (en) Iodinated bis(aminobenzoic acids) and esters thereof
US3883535A (en) Radiopaque derivatives of triiodobenzoic acid with heterocyclic side chains
US3666800A (en) Substituted triiodoisophthalamic acids
US3734953A (en) Tris-triiodoisophthalamic acids and derivatives
US3541141A (en) Bis-triiodoisophthalamic acid compounds
US3210412A (en) m-(alkanamidoalkanamido)-2, 4, 6-triiodobenzoic acid compounds
US3721701A (en) Radiopaque triiodoalkylureido benzoic acids
AU665968B2 (en) New non ionic iodized agents for X-ray contrasting, method for preparing them and galenical compositions containing them
US3660469A (en) Bis-triiodoisophthalamic acid compounds
US3666799A (en) Triiodated toluic acids
US3910989A (en) N-triiodobenzyl-carbamic acid derivatives
US3051745A (en) New iodine-containing aminobenzoic acid amides and a method of producing the same
JPS63500522A (en) Nonionic polyol contrast media from ionic contrast media
US3660466A (en) 2 4 6-triiodobenzoic acid derivatives